By Amanda Nakhul, Biomedical Sciences c/o 2027 Precision is key in multiple aspects of our lives, including medicine. Diseases such as cancer, a disease in which abnormal cells divide uncontrollably and destroy body tissue, can be treated with imatinib. The FDA recently approved the first oral liquid formulation of imatinib: a revolutionary drug redefining cancer…

By Ansha Hamid PharmD Candidate c/o 2027 Schizophrenia is a severe mental illness that is described by a list of debilitating symptoms, including disorganized thoughts and behaviors, out-of-touch experiences, hallucinations, and significant social and occupational dysfunction. Existing therapies predominantly rely on antipsychotic medications targeting dopamine receptors and offer only some relief. However, they often have…

By: Nivaj Haque PharmD Candidate c/o 2027 The pharmaceutical industry is undergoing significant changes in the background as new government policies are affecting the development, approval, and sale of drugs. These changes are affecting the staffing at the regulatory agencies, drug pricing, and international trade. They are also affecting pharmaceutical companies, healthcare providers and patients…

By: Rosa Kang PharmD Candidate c/o 2027 Dr. Aaron Muth, Ph.D., is currently an Associate Professor in the Department of Pharmaceutical Sciences. He has been teaching medicinal chemistry at St. John’s University as Assistant Professor since 2016 and Associate Professor since 2022. In 2024, he was  appointed the Director of the Master of Science in…

By: Sariah Grant PharmD Candidate c/o 2027 Color additives have long played a crucial role in the appearance and appeal of many foods and pharmaceutical products.1 From vibrant candies to easily identifiable medications, synthetic dyes such as Food, Drug and Cosmetics (FD&C) Red Dye No.3, have been used for decades. However, growing concerns over its safety…